Literature DB >> 32033735

Metformin, rosiglitazone, or both for obese women with polycystic ovary syndrome?

Sushila Arya1, Karl R Hansen1, Robert A Wild1.   

Abstract

Entities:  

Year:  2020        PMID： 32033735     DOI： 10.1016/j.fertnstert.2019.10.006

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


× No keyword cloud information.
  3 in total

Review 1.  The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Yuanyuan Guan; Dongjun Wang; Huaien Bu; Tieniu Zhao; Hongwu Wang
Journal:  Int J Endocrinol       Date:  2020-09-16       Impact factor: 3.257

Review 2.  Factors Associated with White Fat Browning: New Regulators of Lipid Metabolism.

Authors:  Peiwen Zhang; Yuxu He; Shuang Wu; Xinrong Li; Xutao Lin; Mailin Gan; Lei Chen; Ye Zhao; Lili Niu; Shunhua Zhang; Xuewei Li; Li Zhu; Linyuan Shen
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

3.  Effect of metformin versus metformin plus liraglutide on gonadal and metabolic profiles in overweight patients with polycystic ovary syndrome.

Authors:  Chuan Xing; Han Zhao; Jiaqi Zhang; Bing He
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-17       Impact factor: 6.055
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.